146 related articles for article (PubMed ID: 29232306)
21. Genetic and expression analysis of SNPs in the human deoxyribonuclease II: SNPs in the promoter region reduce its in vivo activity through decreased promoter activity.
Kimura-Kataoka K; Yasuda T; Fujihara J; Toga T; Ono R; Otsuka Y; Ueki M; Iida R; Sano R; Nakajima T; Kominato Y; Kato H; Takeshita H
Electrophoresis; 2012 Sep; 33(18):2852-8. PubMed ID: 23019102
[TBL] [Abstract][Full Text] [Related]
22. Angiotensinogen promoter B-haplotype associated with cerebral small vessel disease enhances basal transcriptional activity.
Schmidt H; Aulchenko YS; Schweighofer N; Schmidt R; Frank S; Kostner GM; Ott E; van Duijn C
Stroke; 2004 Nov; 35(11):2592-7. PubMed ID: 15472104
[TBL] [Abstract][Full Text] [Related]
23. Inter-individual variations and modulators of MDR1 transport activity in human placenta.
Wang X; Song Y; Wu D; Li Q; Lu S; Li X; Huang H; Zhang J
Placenta; 2020 Aug; 97():46-50. PubMed ID: 32792062
[TBL] [Abstract][Full Text] [Related]
24. Combined Influence of Genetic Polymorphism and DNA Methylation on ABCB1 Expression and Function in Healthy Chinese Males.
Wu LX; Zhao HB; Wen CJ; Li Y; Shao YY; Yang Z; Zhou HH
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):627-634. PubMed ID: 27683186
[TBL] [Abstract][Full Text] [Related]
25. Importance of selected ABCB1 SNPs for the level of severity of depressive symptoms and effectiveness of recurrent depressive disorder therapy.
Jeleń A; Świechowski R; Żebrowska-Nawrocka M; Sałagacka-Kubiak A; Szmajda-Krygier D; Gałecki P; Balcerczak E
Gene; 2023 Jan; 851():147021. PubMed ID: 36356904
[TBL] [Abstract][Full Text] [Related]
26. Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population.
Jeannesson E; Albertini L; Siest G; Gomes AM; Ribeiro V; Aslanidis C; Schmitz G; Visvikis-Siest S
Fundam Clin Pharmacol; 2007 Aug; 21(4):411-8. PubMed ID: 17635180
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability.
Wang D; Johnson AD; Papp AC; Kroetz DL; Sadée W
Pharmacogenet Genomics; 2005 Oct; 15(10):693-704. PubMed ID: 16141795
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4.
Doricakova A; Theile D; Weiss J; Vrzal R
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):49-59. PubMed ID: 27678410
[TBL] [Abstract][Full Text] [Related]
29. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry.
Baena A; Leung JY; Sullivan AD; Landires I; Vasquez-Luna N; Quiñones-Berrocal J; Fraser PA; Uko GP; Delgado JC; Clavijo OP; Thim S; Meshnick SR; Nyirenda T; Yunis EJ; Goldfeld AE
Genes Immun; 2002 Dec; 3(8):482-7. PubMed ID: 12486607
[TBL] [Abstract][Full Text] [Related]
30. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.
Kroetz DL; Pauli-Magnus C; Hodges LM; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; DeYoung J; Taylor T; Carlson EJ; Herskowitz I; Giacomini KM; Clark AG;
Pharmacogenetics; 2003 Aug; 13(8):481-94. PubMed ID: 12893986
[TBL] [Abstract][Full Text] [Related]
31. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients.
Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R
Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936
[TBL] [Abstract][Full Text] [Related]
32. Functional Assessment of Clubfoot Associated HOXA9, TPM1, and TPM2 Variants Suggests a Potential Gene Regulation Mechanism.
Weymouth KS; Blanton SH; Powell T; Patel CV; Savill SA; Hecht JT
Clin Orthop Relat Res; 2016 Jul; 474(7):1726-35. PubMed ID: 27020427
[TBL] [Abstract][Full Text] [Related]
33. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability.
Potocnik U; Glavac D; Dean M
Cancer Genet Cytogenet; 2008 May; 183(1):28-34. PubMed ID: 18474294
[TBL] [Abstract][Full Text] [Related]
34. Association between a common IL10 distal promoter haplotype and IgE production in individuals with atopic dermatitis.
Lacy K; Archer C; Wood N; Bidwell J
Int J Immunogenet; 2009 Aug; 36(4):213-6. PubMed ID: 19552724
[TBL] [Abstract][Full Text] [Related]
35. Distinct single nucleotide polymorphism pattern at the FUT2 promoter among human populations.
Soejima M; Koda Y
Ann Hematol; 2008 Jan; 87(1):19-25. PubMed ID: 17805536
[TBL] [Abstract][Full Text] [Related]
36. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.
Drysdale CM; McGraw DW; Stack CB; Stephens JC; Judson RS; Nandabalan K; Arnold K; Ruano G; Liggett SB
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10483-8. PubMed ID: 10984540
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
[TBL] [Abstract][Full Text] [Related]
38. Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin.
Paquette J; Bessette B; Ledru E; Deal C
Endocrinology; 2007 Dec; 148(12):6007-18. PubMed ID: 17823260
[TBL] [Abstract][Full Text] [Related]
39. Genotype and haplotype analysis of ABCB1 at 1236, 2677 and 3435 among systemic sclerosis patients.
Barańska M; Rychlik-Sych M; Skrętkowicz J; Dudarewicz M; Dziankowska-Bartkowiak B; Owczarek J; Waszczykowska E
Autoimmunity; 2017 Aug; 50(5):277-282. PubMed ID: 28534442
[TBL] [Abstract][Full Text] [Related]
40. Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans.
Macdonald N; Gledhill A
Arch Toxicol; 2007 Aug; 81(8):553-63. PubMed ID: 17354009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
